Impact of carboplatin and cisplatin shortages on treatment patterns ...

We observed decreased platinum use across multiple cancers during the shortage period, most notably for met NSCLC and EC, suggesting shortages led oncologists ...

This study examined how shortages in 2023 impacted carboplatin and cisplatin usage across seven cancer types. Using real-world data from US ...

2023 Chemotherapy Shortages Drove Altered Treatment Plans ...

The 2023 cisplatin shortage led to increased use of alternative chemotherapy agents, raising treatment costs for head and neck cancer.

Carboplatin Shortage: The Impact of Drugs in Short Supply Nationwide

The limited supply of carboplatin and shortage of cisplatin, a similar platinum-based chemotherapy drug, has sparked concerns among health care ...

Impact of carboplatin and cisplatin shortages on treatment patterns ...

Request PDF | Impact of carboplatin and cisplatin shortages on treatment patterns in patients with metastatic solid tumors. | 11149 Background: The United ...

Cisplatin Shortage Shifted Chemo Utilization to Costlier Therapies ...

Results from the ASCO presentation reveal that from May to August 2023, cisplatin use decreased by 15%, with increases of carboplatin by 40%, ...

FDA marks cisplatin drug shortage as resolved - Urology Times

Findings showed that 70% of centers were lacking an adequate supply of cisplatin during the shortage in June 2023, compared with only 7% of ...

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs ...

In both adult and pediatric settings, some community cancer centers are unable to treat patients due to shortages in carboplatin and cisplatin, ...

Cisplatin versus carboplatin based regimens for the treatment of ...

In practice in the United States, most patients who undergo treatment for metastatic NSCLC are treated with a carboplatin-based regimen, in a recent analysis of ...

New Study Highlights Long-lasting Effects of Cancer Drug Shortages

The cisplatin drug shortage in 2023 led to an increased use of alternative drugs and higher costs for people with head and neck cancers, ...

News Details - NCCN

In June 2023, 70% of centers surveyed were also lacking adequate supply for cisplatin. In the latest survey, only 11% of surveyed centers ...

Impact of Oncology Drug Shortages on Patient Therapy

Changes from paclitaxel to docetaxel accounted for 17 of 23 (73.9%) therapy changes. The use of paclitaxel decreased from 11.4% (24 of 211) in August-September ...

Lack of Information Across Supply Chain Exacerbating Oncology ...

In survey results included in the paper, more than 94% of respondents reported an impact on pharmacy operations and patient care due to ...

Petrylak Provides Perspective on the Nationwide Cisplatin ... - OncLive

The ongoing shortage of carboplatin and cisplatin across healthcare systems in the United States calls the current reliance on overseas ...

'Nothing Rivaled This': Navigating the Oncology Drug Shortage

The US Food and Drug Administration (FDA) first reported shortages of cisplatin and carboplatin in February 2023. On its website, the FDA listed ...

Study Finds Cisplatin Shortage Led to Treatment Alternatives for ...

The increased use of alternative drugs corresponded to the decrease in cisplatin use, with new starts shifting to carboplatin (with or without ...

Vizient Evaluating the impact of the oncology drug shortage

If the shortage becomes more critical, consider reserving carboplatin and cisplatin for curative intent treatment. • Consult with your ...

ACCC Statement on Chemotherapy Drug Shortages

Platinum drug shortages were first reported to the U.S. Food and Drug Administration (FDA) on February 10, 20231. In a recent survey by the ...

News Details - NCCN

93% of cancer centers surveyed report a shortage of carboplatin and 70% report shortages for cisplatin; two medications that are used in combination to cure ...

ASCO's Julie Gralow: At least 100,000 (and up to 500,000) cancer ...

But what makes this platinum—cisplatin and carboplatin—shortage in particular a big problem is just how many cancer types rely on these drugs as ...